Giri Rajahram
@GSRajahram
Followers
953
Following
11K
Media
160
Statuses
4K
š²š¾ Infectious Diseases Physician š©ŗ ā¢ Researcher ā¢ Global Health š ā¢ USM, RCPE, LSTM, Oxfordā¢ #tropicalmedicine #globalhealth
Kota Kinabalu
Joined May 2015
Graduated with MSc in International Health & Tropical Medicine with distinction from @UniofOxford. Thrilled to have been able to work on vaccine immunogenicity for my dissertation. Indebted with gratitude to all who made this possible. Thank you @OxIHTM @whtrust_ox @KebleOxford!
25
8
158
RT @AMRWISE360: šØ BORNEO ANTIMICROBIAL STEWARDSHIP SUMMIT (BAMSS) 2025.š
26ā27 Sept 2025.š Auditorium Hall, Centre for Postgraduate Studiesā¦.
0
4
0
RT @ADVANCE__ID: āØWeāre excited to share that our Health Economics Interest Group had its very first meet up session yesterday! Thank you tā¦.
0
2
0
RT @DrToddLee: @snap_trial is the little engine that could! Congratulations on passing 4500 participants. @syctong @Josh_S_Davis
https://tā¦.
0
4
0
RT @akademisains: A monumental achievement for the Malaysian scientific community! Congratulations to Dr Ravigadevi Sambanthamurthi FASc onā¦.
0
5
0
RT @ADVANCE__ID: Weāre setting up a Health Economics Interest Group at ADVANCE-ID and weāre looking for collaborators to join us! . ā
Cliniā¦.
0
3
0
Another brilliant episode on #communicable hosted by Dr @ErinMcCreary & Dr Angela Huttner from practice changing @snap_trial with @syctong & @Josh_S_Davis on the results, which was recently presented at #ESCMIDGlobal2025. @ESCMID @CMIComms
1
4
11
RT @gardp_amr: šØ This is Big!. New GARDP research shows that people with multidrug-resistant infections in LMICs are not receiving the apprā¦.
0
9
0
RT @bencowling88: (1/5) I would like to highlight one very interesting secondary observation about the impact of non-pharmaceutical interveā¦.
0
7
0
Nice summary by @PaulSaxMD on the first of @snap_trial results recently presented #ESCMIDGlobal2025. Congratulations, @syctong @Josh_S_Davis & all participating sites, for answering these questions. Looking forward to its publication & other practice changing answers soon.
The SNAP trial may finally resolve some of the longest-running debates in SAB management (cefazolin vs semi-synthetic PCN? Is PCN really active vs PSSA?). Congrats to @syctong @Josh_S_Davis, and the global team who made this ambitious trial happen.
1
0
5
RT @bryan_p_white: SNAP/COLCEBA trial session starting now @syctong @Josh_S_Davis @ABsteward .Staph aureus causes 1 million deaths per yearā¦.
0
35
0
RT @syctong: Amazing summary of the SNAP/CLOCEBA session from yestereday #ESCMIDGlobal. Thanks for posting @bryan_p_white. Nailed all the kā¦.
0
7
0
RT @BradSpellberg: Here's a different perspective. We agree the trial is very important. I dont agree that the fact that I do not considerā¦.
0
7
0
RT @padstamundo: Big SNAP trial news at #ESCMIDGlobal - PSSA arm stopped early due to increased AKI with fluclox and lower mortality in penā¦.
0
8
0
RT @drtimothyli: Cefazolin vs (flu)cloxacillin for MSSA BSI. āNon-inferior 90-day mortality .āā¬ļøAKI. Also:.ā¬ļødosing frequency.ā¬ļøphlebitisā¦.
0
38
0
RT @padstamundo: #ESCMIDGlobal @snap_trial Well that really does seem to sign the death warrant for flucloxacillin in MSSA bacteraemia asā¦.
0
12
0
RT @ABsteward: The most anticipated RCT in ID.š„SNAP RCTš„The largest RCT 2 date in SA bactermia.N:1341 .Cefazolin Vs ASPs ((flu)cloxacillin)ā¦.
0
88
0
RT @Josh_S_Davis: Excited to announce that we randomised our first patient into the #ROADMAPtrial today! First of thousands, answering impoā¦.
roadmaptrial.com
Explore our website to learn more about our trial, team, and how you can get involved in shaping the future of PJI treatment.
0
10
0
RT @BioethicsMORU: Is there epistemic injustice in global AMR research? Hereās what we think
cell.com
This commentary explores whether there is epistemic injustice in global antimicrobial resistance (AMR) research ā who sets priorities, who produces knowledge, and which types of knowledge are valued....
0
4
0
RT @syctong: Excited that at #ESCMIDGlobal 2025, SNAP trial results for PSSA and MSSA silo backbone domains will be presented. What's moreā¦.
0
13
0
Thank you @markcheongwl, for the opportunity to contribute to this thoughtful piece, led by Dr @BillyRosaPhD, published in @TheLancetInfDis. Tackling a pertinent yet complex clinical care issue through a comprehensive multidisciplinary approach šš¾
Very pleased to share our latest paper in @TheLancetInfDis. This paper considers the complex issues of antimicrobials at the end-of-life, including nonclinical factors that must be navigated in the dying process. Thanks to @BillyRosaPhD for leading this!.
2
5
10